Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer

Figure 11  Nomogram generation for the prediction of 3- and 5-year survival. A: Development of a nomogram for estimating 1-, 2-, 3-and 5-year survival probabilities of breast cancer patients using the The Cancer Genome Atlas (TCGA) database; B and C: The 3- and 5-year area under the curves of nomogram, stage, CAFPS using the TCGA database; D and E: The 3- and 5-year calibration curves for predicting overall survival.